Presentation Information
[PO-007]CLINICAL EFFECTIVENESS AND SAFETY OF VEDOLIZUMAB IN CHINESE BIOLOGICS EXPOSURE PATIENTS WITH CROHN’S DISEASE, SUBGROUP RESULTS FROM 2ND INTERIM ANALYSIS OF VALUE STUDY
Baili Chen1, Lan Zhong2, Yali Zhang3, Jinhai Wang4, Xiaoyu Qian5, *Fang Zhou5, Minhu Chen6 (1. The First Affiliated Hospital, Sun Yat-sen University, Guangzhou, China, 510080, 2. Shanghai East Hospital, Tongji University School of Medicine, Shanghai 200120, China, 3. Department of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China.510515, 4. The Second Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China. 710000, 5. Takeda Pharmaceutical Company, Shanghai, China. 200126, 6. The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China 510062)
Password required to view
Enter the password to view the abstracts.
The password will be emailed to those who have completed the registration.
The password will be emailed to those who have completed the registration.
Comment
To browse or post comments, you must log in.Log in